Summary
Thiazide-type diuretic drugs modify the lipoprotein profile when used in the short term treatment of hypertension. Total cholesterol increases by 6 to 7% on average because of raised concentrations of low density or very low density lipoprotein cholesterol or both. High density lipoprotein cholesterol does not change. Spironolactone has a lesser effect on lipids than do thiazides. In contrast, the methylindoline compound, Indapamide, a diuretic with vasodilator activity, has produced no adverse effects on lipids or lipoproteins. Long term data on thiazide monotherapy are sparse but suggest a persistence of the lipid effect for as long as 6 years of treatment. The clinical impact of these lipid changes is unclear. Although clinical trials have proved the benefit of lowering cholesterol on the incidence of coronary heart disease, the clinical significance of these diuretic-induced increases is unknown. A clinical trial will be required to resolve the issue by comparing antihypertensive drugs with and without adverse effects on the lipid profile. Because coronary heart disease is the most common complication of mild hypertension, and as diuretic-based regimens have not succeeded in curbing it, resolution of this concern is important.
Similar content being viewed by others
References
Amery A, Birkenhäger W, Bulpitt C, Clement D, Deruyttee M, et al. Influence of antihypertensive therapy on serum cholesterol in elderly hypertensive patients. Acta Cardiologica 37: 235–244, 1982
Ames RP. Coronary heart disease and the treatment of hypertension: impact of diuretics on serum lipids and glucose. Journal of Cardiovascular Pharmacology 6(Suppl. 3): S466–S473, 1984
Ames RP. The effects of antihypertensive drugs on serum lipids and lipoproteins. I. Diuretics; II. non-diuretic drugs. Drugs 32: 260–278; 335-357, 1986
Ames RP. The influence of non-beta-blocking drugs on the lipid profile: are diuretics outclassed as initial therapy for hypertension? American Heart Journal 114: 998–1006, 1987
Ames RP, Hill P. Raised serum lipid concentrations during diuretic treatment of hypertension: a study of predictive indexes. Clinical Science and Molecular Medicine 55(Suppl. 4): 311S–314S, 1978
Ames RP, Hill P. Antihypertensive therapy and the risk of coronary heart disease. Journal of Cardiovascular Pharmacology 4(Suppl. 2): S206–S212, 1982
Ames RP, Peacock P. Serum cholesterol during treatment of hypertension with diuretic drugs. Archives of Internal Medicine 144: 710–714, 1984
Berglund G, Andersson O. Beta blockers or diuretics in hypertension? A six-year follow-up of blood pressure and metabolic side effects. Lancet 1: 744–747, 1981
Boehringer K, Weidmann P, Mordasini R, Schiffl H, Bachmann C, et al. Menopause-dependent plasma lipoprotein alterations in diuretic-treated women. Annals of Internal Medicine 97: 206–209, 1982
Crisp AJ, Kennedy PGE, Hoffbrand BI, Ebutt AF, Carruthers M. Lipids and lipoprotein fractions after cyclopenthiazide and Oxprenolol: a double-blind crossover study. Current Medical Research and Opinion 7: 101–103, 1980
Cruickshank JM, Thorp JM, Zacharias FJ. Benefits and potential harm of lowering high blood pressure. Lancet 1: 581–584, 1987
Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, et al. Helsinki Heart Study: primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia. New England Journal of Medicine 317: 1237–1245, 1987
Goldman AI, Steele BW, Schnaper HW, Fitz AE, Frohlich ED, et al. Serum lipoprotein levels during chlorthalidone therapy. Journal of the American Medical Association 224: 1691–1695, 1980
Greenberg G, Brennan PJ, Miall WE. Effects of diuretic and beta-blocker therapy in the Medical Research Council Trial. American Journal of Medicine 76(2A): 45–51, 1984
Grimm Jr RH, Leon AS, Hunninghake DB, Blackburn H. Diuretics and plasma lipids: effects of thiazides and spironolactone. In Noseda et al. (Eds) Lipoproteins and coronary atherosclerosis, pp. 371–376, Elsevier Biomedical Press, Amsterdam 1982
Helgeland A, Hjermann I, Leren P, Enger S, Holme I. High density lipoprotein cholesterol and antihypertensive drugs: the Oslo study. British Medical Journal 2: 403, 1978
Johnson BF. The emerging problem of plasma lipid changes during antihypertensive therapy. Journal of Cardiovascular Pharmacology 4(Suppl. 2): S213–S221, 1982
Joos C, Kewitz H, Reinhold-Kourniati D. Effects of diuretics on plasma lipoproteins in healthy men. European Journal of Clinical Pharmacology 17: 251–257, 1980
Labardens P, Freyria JL. Indapamide and carbohydrate-lipid metabolism in hypertensives. Medicographia 6(Suppl. 1): 18–22, 1984
Lasser NL, Grandits G, Caggiulla AW, Cutler JA, Grimm Jr RH, et al. Effects of antihypertensive therapy on plasma lipids and lipoproteins in the Multiple Risk Factor Intervention Trial. American Journal of Medicine 76(2A): 52–66, 1984
Leon AS, Agre J, McNally C, Bell C, Neibling M, et al. Blood lipid effects of antihypertensive therapy: a double-blind comparison of the effects of methyldopa and propranolol. Journal of Clinical Pharmacology 24: 209–217, 1984
Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. Journal of the American Medical Association 251: 351–364, 1984
Middeke M, Weisweiler P, Schwandt P, Holzgreve H. Serum lipoproteins during antihypertensive therapy with beta blockers and diuretics: a controlled long-term comparative trial. Clinical Cardiology 10: 94–98, 1987
Morledge JH. Clinical efficacy and safety of indapamide in essential hypertension. American Heart Journal 106: 229–232, 1983
Samuelsson O, Wilhelmsen L, Andersson OK, Pennert K, Berglund G. Cardiovascular morbidity in relation to change in blood pressure and serum cholesterol levels in treated hypertension. Journal of the American Medical Association 258: 1768–1776, 1987
Scalabrino A, Galeone F, Giuntoli F, Guidi G, Birindelli A, et al. Clinical investigation on long-term effects of indapamide in patients with essential hypertension. Current Therapeutic Research 35: 17–22, 1984
Stewart J McD G. Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension. Lancet 1: 861–865, 1979
Veterans Administration Cooperative Study Group on Antihypertensive Agents. Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. II. Results of long-term therapy. Journal of the American Medical Association 248: 2004–2011, 1982
Weidmann P, Gerber A, Mordasini R. Effects of antihypertensive therapy on serum lipoproteins. Hypertension 5(Suppl. III): 120–131, 1983
Williams WR, Scheider KA, Borhani NO, Schnaper HW, Slotkoff LM, et al. The relationship between diuretics and serum cholesterol in Hypertension Detection and Follow-up Program participants. American Journal of Preventive Medicine 2: 248–255, 1986
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ames, R. Effects of Diuretic Drugs on the Lipid Profile. Drugs 36 (Suppl 2), 33–40 (1988). https://doi.org/10.2165/00003495-198800362-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198800362-00007